Ticker Symbol: VLON

Vallon Pharmaceuticals Inc

$4.80 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001824293

Company Profile

Vallon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company, headquartered in Philadelphia, PA. The Company is focused on the development of new medications to help patients with central nervous system (CNS) disorders. The Company’s lead investigational product candidate, ADAIR, is a novel abuse deterrent formulation of amphetamine immediate release being developed for the treatment of ADHD and narcolepsy.

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Standard Industrial Classification Code (SIC code): 2834

Address: N/A

Website: www.vallon-pharma.com

CEO: N/A

Tags: N/A

Pricing

Last Updated: December 31, 1969 07:00 PM EST

Previous Close: -

Change: - ( 0.00%)

Days Range: $0.38 - $360.00

Beta: -

52wk. High: $1,953.00

52wk. Low: $184.86

Ytd. Change 37.93%

50 Day Moving Average: $375.25

200 Day Moving Average: $317.93

Shares Outstanding: 13482342

Valuation

Market Cap: 970.7B

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A